Detalhe da pesquisa
1.
L-2-hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models.
J Clin Invest;
2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743486
2.
Transcriptome-wide quantitative profiling of PUS7-dependent pseudouridylation by nanopore direct long read RNA sequencing.
bioRxiv;
2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352483
3.
Are markers of survival associated with perioperative outcomes for tumor thrombectomy patients?
Urol Oncol;
41(8): 358.e17-358.e24, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301680
4.
Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.
Cancer Res;
83(13): 2248-2261, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057874
5.
Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation.
Front Endocrinol (Lausanne);
13: 932286, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36133305
6.
The TGF-ß/HDAC7 axis suppresses TCA cycle metabolism in renal cancer.
JCI Insight;
6(22)2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609963
7.
The oncometabolite L-2-hydroxyglutarate is a common product of dipteran larval development.
Insect Biochem Mol Biol;
127: 103493, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33157229
8.
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
Dis Model Mech;
13(11)2020 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928875
9.
Metastatic prostate cancer to an ischiorectal fossa lymph node identified on multiparametric magnetic resonance imaging.
Urol Ann;
12(2): 172-175, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565657
10.
PRDM16 suppresses HIF-targeted gene expression in kidney cancer.
J Exp Med;
217(6)2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251515
11.
PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression.
Matrix Biol;
89: 43-58, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31982456
12.
14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation.
J Biol Chem;
295(6): 1754-1766, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31901078
13.
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Mol Cancer Res;
17(1): 84-96, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30131446
14.
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.
Clin Cancer Res;
24(24): 6433-6446, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108105
15.
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.
Prostate;
78(16): 1311-1320, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051493
16.
Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.
Oncotarget;
8(17): 29220-29232, 2017 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418903
17.
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
PLoS One;
11(8): e0160924, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27574806
18.
Genetics of renal cancer: focus on MTOR.
Aging (Albany NY);
8(3): 421-2, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27017990
19.
High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
PLoS One;
10(9): e0139267, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406598
20.
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Oncotarget;
6(20): 17895-910, 2015 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255626